Trials / Completed
CompletedNCT07508501
Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets
A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is a single-center, randomized, open-label, two-period crossover design to evaluate the effect of food on the pharmacokinetic profile of ammoxetine hydrochloride enteric-coated tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ammoxetine hydrochloride enteric-coated tablets | Single-dose of 40mg of ammoxetine hydrochloride enteric-coated tablets |
| DRUG | Ammoxetine hydrochloride enteric-coated tablets | Single-dose of 40 mg of ammoxetine hydrochloride enteric-coated tablets |
Timeline
- Start date
- 2023-02-08
- Primary completion
- 2023-02-24
- Completion
- 2023-04-04
- First posted
- 2026-04-02
- Last updated
- 2026-04-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07508501. Inclusion in this directory is not an endorsement.